A Multicentre Trial of Nerve-Spring Radical Hysterectomy vs. Radical Hysterectomy for Cervical Cancer

N

Nanfang Hospital, Southern Medical University

Status

Unknown

Conditions

Cervical Cancer

Treatments

Procedure: radical hysterectomy
Procedure: Nerve-spring radical hysterectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT01886508
NCT00270426

Details and patient eligibility

About

The investigators designed this multicentre randomized study to investigate the clinical benefits of nerve-spring radical hysterectomy for cervical cancer. Patients with FIGO stage Ia2, Ib1, IIa1 and FIGO stage Ib2, IIa2 after neoadjuvant chemotherapy are randomized to either nerve-spring radical hysterectomy or radical hysterectomy. The primary endpoint are urodynamic outcome including maximum flow rate, residual volume, maximum vesical compliace, cystomctric capacity at first desire, and maximum cystomctric capacity. A total 240 patients (120 per treatment arm) are planned to accrue for this study within 7 years.

Enrollment

240 estimated patients

Sex

Female

Ages

17 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • FIGO(2009) stage Ia2, Ib1, and IIa1 Untreated cervical cancer OR FIGO(2009) stage Ib2 and IIa2 cervical cancer that possible to surgery after neoadjuvant chemotherapy
  • Possible to radical hysterectomy or nerve-spring radical hysterectomy
  • Age: 17 to 60 years
  • No complication during operation
  • Written informed consent

Exclusion criteria

  • patients who underwent radiotherapy
  • Pathologically diagnosed Pathologically diagnosed squamous carcinoma, Small Cell Carcinoma, Small Cell Carcinoma
  • Patients who have uncontrolled diabetes or uncontrolled hypertension
  • patients with neurogenic bladder dysfunction
  • patients with uterine prolapse
  • Patients with psychiatric illness
  • Patients who have active infection
  • Patients who have had heart failure, unstable angina, or myocardial infarction within the past 6 months
  • Patients who are unable to undergo radical hysterectomy for complication of excessive obesity, liver cirrhosis, or bleeding tendency

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

240 participants in 2 patient groups

NSRH
Experimental group
Description:
patients in Arm NSRH undergo nerve-spring radical hysterectomy (NSRH)
Treatment:
Procedure: Nerve-spring radical hysterectomy
RH
Active Comparator group
Description:
patients in Arm RH undergo radical hysterectomy (RH)
Treatment:
Procedure: radical hysterectomy

Trial contacts and locations

1

Loading...

Central trial contact

Chenlin Chen, M.D.,Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems